These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 29662617)
1. Premature ovarian aging in Ben-Aharon I; Levi M; Margel D; Yerushalmi R; Rizel S; Perry S; Sharon E; Hasky N; Abir R; Fisch B; Tobar A; Shalgi R; Stemmer SM Oncotarget; 2018 Mar; 9(22):15931-15941. PubMed ID: 29662617 [TBL] [Abstract][Full Text] [Related]
2. Serum AMH levels in healthy women from BRCA1/2 mutated families: are they reduced? van Tilborg TC; Derks-Smeets IA; Bos AM; Oosterwijk JC; van Golde RJ; de Die-Smulders CE; van der Kolk LE; van Zelst-Stams WA; Velthuizen ME; Hoek A; Eijkemans MJ; Laven JS; Ausems MG; Broekmans FJ Hum Reprod; 2016 Nov; 31(11):2651-2659. PubMed ID: 27907901 [TBL] [Abstract][Full Text] [Related]
3. Association of Son KA; Lee DY; Choi D Front Endocrinol (Lausanne); 2019; 10():235. PubMed ID: 31031710 [No Abstract] [Full Text] [Related]
4. BRCA1 germline mutations may be associated with reduced ovarian reserve. Wang ET; Pisarska MD; Bresee C; Chen YD; Lester J; Afshar Y; Alexander C; Karlan BY Fertil Steril; 2014 Dec; 102(6):1723-8. PubMed ID: 25256924 [TBL] [Abstract][Full Text] [Related]
5. Do BRCA1 and BRCA2 gene mutation carriers have a reduced ovarian reserve? Protocol for a prospective observational study. Winship AL; Willson C; Hansen KR; Hutt KJ; Hickey M BMJ Open; 2019 Nov; 9(11):e033810. PubMed ID: 31772111 [TBL] [Abstract][Full Text] [Related]
6. Antimüllerian hormone levels are lower in BRCA2 mutation carriers. Johnson L; Sammel MD; Domchek S; Schanne A; Prewitt M; Gracia C Fertil Steril; 2017 May; 107(5):1256-1265.e6. PubMed ID: 28476184 [TBL] [Abstract][Full Text] [Related]
7. Anti-Müllerian hormone serum concentrations of women with germline BRCA1 or BRCA2 mutations. Phillips KA; Collins IM; Milne RL; McLachlan SA; Friedlander M; Hickey M; Stern C; Hopper JL; Fisher R; Kannemeyer G; Picken S; Smith CD; Kelsey TW; Anderson RA; Hum Reprod; 2016 May; 31(5):1126-32. PubMed ID: 27094481 [TBL] [Abstract][Full Text] [Related]
8. BRCA carriers have similar reproductive potential at baseline to noncarriers: comparisons in cancer and cancer-free cohorts undergoing fertility preservation. Gunnala V; Fields J; Irani M; D'Angelo D; Xu K; Schattman G; Rosenwaks Z Fertil Steril; 2019 Feb; 111(2):363-371. PubMed ID: 30527950 [TBL] [Abstract][Full Text] [Related]
9. BRCA1/2 gene mutations do not affect the capacity of oocytes from breast cancer candidates for fertility preservation to mature in vitro. Grynberg M; Dagher Hayeck B; Papanikolaou EG; Sifer C; Sermondade N; Sonigo C Hum Reprod; 2019 Feb; 34(2):374-379. PubMed ID: 30561604 [TBL] [Abstract][Full Text] [Related]
10. BRCA mutation carriers do not have compromised ovarian reserve. Michaelson-Cohen R; Mor P; Srebnik N; Beller U; Levy-Lahad E; Eldar-Geva T Int J Gynecol Cancer; 2014 Feb; 24(2):233-7. PubMed ID: 24378620 [TBL] [Abstract][Full Text] [Related]
11. Assessment of ovarian reserve and reproductive outcomes in Ponce J; Fernandez-Gonzalez S; Calvo I; Climent M; Peñafiel J; Feliubadaló L; Teulé A; Lázaro C; Brunet JM; Candás-Estébanez B; Durán Retamal M Int J Gynecol Cancer; 2020 Jan; 30(1):83-88. PubMed ID: 31780568 [TBL] [Abstract][Full Text] [Related]
12. Increased chemotherapy-induced ovarian reserve loss in women with germline BRCA mutations due to oocyte deoxyribonucleic acid double strand break repair deficiency. Oktay KH; Bedoschi G; Goldfarb SB; Taylan E; Titus S; Palomaki GE; Cigler T; Robson M; Dickler MN Fertil Steril; 2020 Jun; 113(6):1251-1260.e1. PubMed ID: 32331767 [TBL] [Abstract][Full Text] [Related]
13. Bilateral prophylactic mastectomy in BRCA mutation carriers: what surgeons need to know. Franceschini G; Di Leone A; Terribile D; Sanchez MA; Masetti R Ann Ital Chir; 2019; 90():1-2. PubMed ID: 30872561 [TBL] [Abstract][Full Text] [Related]
14. Association of BRCA1 Mutations with Impaired Ovarian Reserve: Connection Between Infertility and Breast/Ovarian Cancer Risk. Giordano S; Garrett-Mayer E; Mittal N; Smith K; Shulman L; Passaglia C; Gradishar W; Pavone ME J Adolesc Young Adult Oncol; 2016 Dec; 5(4):337-343. PubMed ID: 27513691 [TBL] [Abstract][Full Text] [Related]
15. Effects of BRCA gene mutation on female reproductive potential: A systematic review. Hu KL; Wang S; Ye X; Zhang D Maturitas; 2020 Jul; 137():11-17. PubMed ID: 32498931 [TBL] [Abstract][Full Text] [Related]
16. Perceptions of risk and reward in BRCA1 and BRCA2 mutation carriers choosing salpingectomy for ovarian cancer prevention. Ghezelayagh TS; Stewart LE; Norquist BM; Bowen DJ; Yu V; Agnew KJ; Pennington KP; Swisher EM Fam Cancer; 2020 Apr; 19(2):143-151. PubMed ID: 32096072 [TBL] [Abstract][Full Text] [Related]
17. Ovarian Aging in Women With BRCA Germline Mutations. Lin W; Titus S; Moy F; Ginsburg ES; Oktay K J Clin Endocrinol Metab; 2017 Oct; 102(10):3839-3847. PubMed ID: 28938488 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of serum anti-Mullerian hormone as a biomarker of early ovarian aging in young women undergoing IVF/ICSI cycle. Lin PY; Huang FJ; Kung FT; Chiang HJ; Lin YJ; Lin YC; Lan KC Int J Clin Exp Pathol; 2014; 7(9):6245-53. PubMed ID: 25337276 [TBL] [Abstract][Full Text] [Related]